abstract |
The present invention provides compounds and pharmaceutical compositions that are substituted pyridyl-linked-xantbines of formula I n nwhich are selective antagonists of A 2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents. |